News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

GlaxoSmithKline (GSK) is Interested in BioMarin Pharmaceutical Inc. (BMRN)...Again?


7/13/2012 7:31:42 AM

GlaxoSmithKline is edging higher amid renewed speculation it could be interested in US group BioMarin. BioMarin, which specialises in rare diseases, saw its shares climb more than 2% on Thursday to $42.39. There has been much talk in recent weeks that the company was a target for a larger pharmaceutical group, and some traders believe news could come soon. A price of up to $65 a share has been mentioned, which would value Biomarin at more than $7bn. Glaxo is currently up 11p at 1446.5p after submitting a new lung disease treatment for US and European approval.

Read at Guardian

comments powered by Disqus
Guardian
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES